The ability of PEG-PBAE NPs to achieve widespread neuronal transgene expression also suggests the potential of the NP-mediated GBA1 gene therapy as a viable therapeutic strategy for other neurodegenerative disorders characterized by lysosomal dysfunction, beyond PD. This evidence concerns the gene GBA1 and Parkinson disease.